Principal Clinical Pharmacologist
Regeneron Pharmaceuticals
Summary
We are looking for a Principal Scientist, Clinical Pharmacology in our Pharmacometrics (PMx) group. The position will report to the Senior Group Director (SGD) within Clinical Pharmacology (CP) in the General Medicine (GM) group. This person will represent Clinical Pharmacology on project teams to provide strategic and scientific expertise to support new and on-going GM clinical programs. This individual is expected to provide significant contributions to PMx deliverables for multiple programs to support the strategies for each program. In addition, this person will prospectively contribute to longer-term development strategies executed over the course of multiple non-clinical experiments, clinical studies and PMx analyses. This person conducts or otherwise oversees the development of PMx analysis plans.
Job description
When & where:
- Work Location: Tarrytown, NY, Warren, NJ or Cambridge, MA
- Work model/flexibility: 4 days per week on site
Discover your role:
- Develop and maintain comprehensive strategic CP development plans for assigned programs with SGD supervision
- Provide CP subject matter expertise and presentations to the Clinical Study Team/ Development Team and Senior Management/Governance meetings with SGD supervision
- Collaborate and assist the Pre-clinical PK/PD Team and research teams to characterize preclinical PK/PD for prediction human PK/PD to accelerate clinical studies and achieve business goals
- Assist in drafting and finalization of clinical study protocols and study analysis plans as well as draft, finalize, and/or review clinical pharmacology reports
- Collaborate with the Medical Writing Team to incorporate PK/PD sections into clinical study reports
- Provide CP support of regulatory documents, communications, and presentations (eg, IND, health authority queries, preparation of BLA summary sections, addressing review inquiries) with SGD supervision
- Represent CP at pre-IND, Type C, preBLA, and other health authority meetings with SGD supervision
- Work closely with Quantitative Pharmacology to develop quantitative strategies and to deliver analyses and technical reports to support strategic development plans
- Actively publish work in scientific literature
This role requires:
- PhD (example Pharmacometrics, Biology, Pharmacology, Engineering), PharmD, MD
- 6+ years of experience in clinical pharmacology
- Strong communications skills to actively engage colleagues cross-functionally at all levels of the organization
- Innovative and flexible mindset, keen scientific interest and solid science background are required.
Requirements
- PhD (example Pharmacometrics, Biology, Pharmacology, Engineering), PharmD, MD
- 6+ years of experience in clinical pharmacology
- Strong communications skills to actively engage colleagues cross-functionally at all levels of the organization
- Innovative and flexible mindset, keen scientific interest and solid science background are required.
Benefits
- Annual bonuses
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.